Cargando…
Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients
BACKGROUND: Hydroxychloroquine with or without azithromycin was one of the common therapies at the beginning of the COVID-19 pandemic. They can prolong QT interval, cause torsade de pointes, and lead to sudden cardiac death. We aimed to assess QT interval prolongation and its risk factors in patient...
Autores principales: | Eftekhar, Seyed Parsa, Kazemi, Sohrab, Barary, Mohammad, Javanian, Mostafa, Ebrahimpour, Soheil, Ziaei, Naghmeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924072/ https://www.ncbi.nlm.nih.gov/pubmed/33688374 http://dx.doi.org/10.1155/2021/6683098 |
Ejemplares similares
-
QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020) -
Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020) -
System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020) -
Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
por: Anupama, B K, et al.
Publicado: (2020) -
Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)